TITLE

N.A.C. and Antibiotics in Cystic Fibrosis

AUTHOR(S)
Lawson, David; Saggers, B. A.
PUB. DATE
January 1965
SOURCE
British Medical Journal;1/30/1965, Vol. 1 Issue 5430, p317
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64057436

 

Related Articles

  • Antibiotics Used to Treat Pulmonary Exacerbations in Cystic Fibrosis Patients.  // Emergency Medicine Reports;4/28/2008, Vol. 29 Issue 10, p121 

    A table that presents the antibiotics used for Cystic Fibrosis patients is presented.

  • Vulvovaginal cadidiasis in young women with cystic fibrosis. Sawyer, Susan M.; Bowes, Glenn; Phelan, Peter D. // BMJ: British Medical Journal (International Edition);6/18/94, Vol. 308 Issue 6944, p1609 

    Reports rate of vulvovaginal candidiasis in women with and without cystic fibrosis. Improvement on survival of young people with cystic fibrosis; Examination on health problems following cystic fibrosis survival; Effect of antibiotic use on women risk of vulvovaginal candidiasis.

  • Knock Out CF Lung Infections. Harrar, Sari; Metcalf, Eric // Prevention;Mar2002, Vol. 54 Issue 3, p151 

    Reports that the antibiotic tobramycin can prevent the bacteria Pseudomonas aeruginosa from infecting the lungs of people with cystic fibrosis.

  • Aggressive Antibiotics: Good or Bad for CF Patients?  // AARC Times;Jun2012, Vol. 36 Issue 6, p68 

    The article focuses on the study conducted by University of Michigan researchers regarding the effect of liberal use of antibiotics in patients with cystic fibrosis (CF).

  • Clinical trial to test success of cystic fibrosis lung infection treatment.  // Biomedical Market Newsletter;4/14/2012, Vol. 21, p1 

    The article informs that the intravenous antibiotics are being tested for treating cystic fibrosis complications effectively in patients with lung infection.

  • First antibiotic inhalation approved for cystic fibrosis. Portyansky, Elena // Drug Topics;2/16/98, Vol. 124 Issue 4, p53 

    Reports that the United States Food and Drug Administration has approved tobramycin, an antibiotic inhalation for the treatment of cystic fibrosis. Information from Ralph Sanks of the Cystic Fibrosis Services Pharmacy; Details on nebulized tobramycin; Availability of this product.

  • Ireland has the highest rate of cystic fibrosis in the world.  // Daily Mail;1/22/2016, p22 

    WHAT IS CYSTIC FIBROSIS?

  • Two biotech IPOs make debut. Investor's Business Daily // Investors Business Daily;9/19/2014, pA02 

    Cystic fibrosis therapy developer

  • NAC (N-Acetyl-L-Cysteine), Natural Decongestant. Sahley, Billie J. // MMRC Health Educator Reports;2008, p1 

    The article specifies the therapeutic uses and health benefits of N-Acetyl-L-Cysteine (NAC). NAC is an essential treatment for bronchitis, cystic fibrosis, asthma, pneumonia, otitis media and chronic sinusitis. NAC is primarily used to reduce mucus strands that eventually lead to reduced...

  • NAC (N-ACETYL-L-CYSTEINE). Birkner, Kathy // MMRC Health Educator Reports;2004, p1 

    The article reports that N-Acetyl-L-Cysteine (NAC) was first produced 30 years ago. NAC is used in the treatment of bronchitis, cystic fibrosis, asthma, pneumonia, otitis media, chronic sinusitis, and the common cold. The common therapeutic functions of NAC have reduced the suffering in many...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics